UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-C
REPORT BY ISSUER OF SECURITIES QUOTED ON
NASDAQ INTERDEALER QUOTATION SYSTEM
FILED PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
AND RULE 13A-17 OR 15D-17 THEREUNDER
The Liposome Company, Inc.
(Exact name of issuer as specified in charter)
One Research Way, Princeton Forrestal Center, Princeton, NJ 08540
(Address of principal Executive offices)
Issuer's telephone number, including area code (609) 452-7060
I. CHANGE IN NUMBER OF SHARES OUTSTANDING
Indicate any change (increase or decrease) of 5% or more in the number of
shares outstanding:
1. Title of Security
Common Stock, par value $.01 per share
2. Number of shares
outstanding before the change 23,982,849
3. Number of shares
outstanding after the change 26,982,849
4. Effective date of
change April 27, 1995 (date of SEC order of effectiveness)
May 5, 1995 (closing date)
5. Method of change:
Specify method (such as merger, acquisition, exchange, distribution, stock
split, reverse split, acquisition of stock for treasury, etc.) Distribution
Give brief description of transaction Public offering of Common Stock
pursuant to
Registration No. 33-58169
II. CHANGE IN NAME OF ISSUER
1. Name prior to
change
2. Name after change
3. Effective date of
charter amendment changing name
4. Date of
shareholder
approval of change, if required
Date May 15, 1995
(Officer's signature & title)
Vice President, General Counsel and
Secretary
